January   | View Newsletter

February    | View Newsletter

March   | View Newsletter

Includes:

• Us TOO Board Welcomes New Member

• FDA Approves Xgeva® (denosumab) to Help Prevent Cancer-Related Bone Injury

• US Panel Backs Provenge® for Medicare

• FDA Panel Rejects Prostate Drugs (Avodart® & Proscar®) for Prostate Cancer Prevention

• Could a Prostate Cancer Treatment Raise Colon Cancer Risk?

• Clinical Staging for Prostate Cancer Can’t Predict Likelihood for Recurrence

• Long-Term Effect of Early Postoperative Pelvic Floor Biofeedback on Continence post-RP

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “Can dogs really smell prostate cancer in urine?”

• Doctor Chodak’s Bottom Line

• Prostate Biopsies Are Not Associated with Increased Mortality

• DHT May Not Affect Prostate Size But May Reduce Bone Mineral Density

• Read more..

Includes:

• Special Burning Issues Supplement: A Systems Pathology Approach to Post-Surgical Patients with Anxiety

• Dutasteride Enhances the Predictive Usefulness of PSA As a Screening Test

• Is Prostate Cancer in Older Men More Deadly?

• Us TOO Names New Board Officers, Another Member for 2011

• Popular Online Prostate Cancer Tool Questioned

• Cancer Blood Test Closer to Market

• Older Men Get Less Effective Cancer Care

• Decision Making in Localized Prostate Cancer: Lessons Learned from an Online Support Group

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – Creatine Supplements

• ADT May Be Tied to Cataracts

• Doctor Chodak’s Bottom Line

• Read more..

Includes:

• Us TOO 2009 Annual Report Now Available

• Focusing on the Stress of Prostate Cancer

• Gene Test May Spot Lethal Prostate Tumors

• First 5-Year Outcomes Published on CyberKnife Radiosurgery for Prostate Cancer

• Improving Active Surveillance Outcome Using Stringent Enrollment Criteria

• Surgery vs. Radiation for High-Risk Disease

• Multidisciplinary vs. 1-on-1 Medical Care

• Prostate Cancer Support Groups, Health Literacy & Consumerism

• PSA & Confirmatory Biopsy in Surveillance

• Cancer Death Rates in African Americans Still High

• Timely Intervention with Zoledronic Acid Beneficial

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “IOM Barely Changes Vitamin D Recommendations”

• Doctor Chodak’s Bottom Line

• Read more..

April   | View Newsletter

May   | View Newsletter

June   | View Newsletter

Includes:

• Study Knocks Diagnostic Value of PSA Velocity

• Imaging Misses Mark in Prostate Cancer

• Large Study Shows Little Need for PSA Testing Beyond 10 Years Post-Surgery

• PSA Testing Declines a Bit

• Genetic Map of Prostate Cancer Cracked

• Disease-Free Survival Following Salvage Cryotherapy for Biopsy-Proven Radiotherapy-Recurrent Prostate Cancer

• Study Suggests Lower PSA Cutoff for Biopsy

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “Resistance Exercises vs. Calcium + Vitamin D”

• Doctor Chodak’s Bottom Line

• Drug (Abiraterone) Works in Most Prostate Cancer Subgroups

• Read more..

• 20% Rise in Number of Cancer Survivors

• PSA Screening Is Higher in Men in Their 70s

• Short Course of ADT Works Well with RT

• Statins + RT More Effective in Prostate Cancer

• New Cancer Drug Heads to Clinical Trials

• Phase I/II Study of TRC105 in Refractory CRPC

• Digoxin Possible Treatment for Prostate Cancer?

• NCCN Continues to Modify Guidelines

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “An aspirin a day may reduce the risk of cancer”

• Doctor Chodak’s Bottom Line

• How Prostate Cancer May Spread to Bone

• Read more..

• FDA Approves Abiraterone

• Early Surgery or Watchful Waiting?

• Biopsy May Progress without PSA Changes

• Study Supports Watchful Waiting for Low-Risk Prostate Cancer

• Another Endothelin Blocker Fails

• Upgrade in Gleason Score Between Biopsies & Pathology Following Radical Prostatectomy

• Overtreatment of Men with Low-Risk Prostate Cancer and Significant Comorbidity

• Phase III Trial of Ipilimumab (NCT01057810)

• Supplements Don’t Prevent Prostate Cancer

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “Is Omega-3 in fish oil really bad for you?”

• Doctor Chodak’s Bottom Line

• Read more..

July   | View Newsletter

August   | View Newsletter

September   | View Newsletter

• Alpharadin (222Radium Chloride) Improves Overall Survival in Men with Metastatic CRPC

• Early PSA Testing & Risk of Long-Term Death

• Surgery Works in Locally-Advanced Disease

• AS Update from the John Hopkins Experience

• Effect of Surgery Delay in Men Undergoing AS

• NADiA ProsVue - A New Prognostic Prostate Cancer Test (for Post-RP Patients)

• Exelixis Drug Shown to Control Solid Tumors

• Fusion of MRI and Prostate Ultrasound

• Intermittent Vs. Continuous ADT

• Circulating Tumor Cells Predict Drug Response

• Ask Doctor Snuffy Myers

• Doctor Chodak’s Bottom Line

• Doc Moyad’s “No Bogus Science” Column – “___ Dietary Supplement Fights/Kills Prostate Cancer? Should Doc Moyad Support It?”

• Read more..

• Medicare Will Pay for Prostate Cancer Drug

• Long-Term Efficacy of the Phase 1-2 Study of MDV3100 in Advanced Prostate Cancer Patients Before and after Docetaxel Therapy

• New Resource Kit from Us TOO for Men with Advanced Prostate Cancer

• Potential Combinability of Custirsen with MDV3100 and Hsp90 Inhibitors to Enhance Anti-Tumor Activity Against Prostate Cancer

• Kyphon® Balloon Kyphoplasty for Treating Spinal Fractures in Prostate Cancer Patients

• Prostate Cancer in Men Less than 50 Years Old: A Comparison of Race and Outcomes

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “You want another reason to lose weight? How about free vitamin D?!”

• Doctor Chodak’s Bottom Line

• Hydrodissection in Nerve-Sparing Radical Prostatectomy Improves Postoperative Potency

• Read more..

• Urine Test May Help Detect / Stratify Prostate Cancer

• For Some Prostate Cancer Patients, Combo Treatment Improved Survival

• Us TOO Names New Board Members for 2011

• Robot Technology May Drive Up Prostate Surgeries

• Letter to the Editors

• New Patient Information Guide for CyberKnife

• Age Adjustment in Active Surveillance

• ADT & 11C-Choline Uptake in PET/CT Scans

• Bone Flare with Abiraterone Treatment

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “Some vegetables may reduce the risk of prostate cancer recurring after treatment”

• Doctor Chodak’s Bottom Line

• Read more..

October   | View Newsletter

November   | View Newsletter

December   | View Newsletter

• ADT Does Not Increase Cardiovascular Risk

• Five Genes Liked to Aggressive Prostate Cancer

• VA Adds to List of Agent Orange-Exposed Ships

• Two Clusterin Studies Released

• Good Long-Term QOL after Brachytherapy

• Dendreon & a Diagnostic for Provenge?

• New Online Tool & Tips on Bone Health

• New Provenge Plant Opens in California

• Valvoline Supports Prostate Cancer Awareness

• Elastography Beats Ultrasound for Detection

• Ask Doctor Snuffy Myers

• Doc Moyad’s “No Bogus Science” Column – “Sage supplement may reduce hot flashes”

• ERG Unrelated to PSA Recurrence w/o ADT

• Doctor Chodak’s Bottom Line

• Read more..

• USPSTF Says PSA Test Does Not Save Lives

• FDA Approves Prolia for Treating Bone Loss in Men and Women on Hormone Ablation

• Erections after Prostate Treatment Predicted by Models

• Us TOO Seeks Board Member Applications

• Ask Doctor Snuffy Myers

• Call to Action – Comment on USPSTF’s Draft Recommendation Statement Against PSA-Based Screening for Prostate Cancer

• SEA Blue Prostate Walk Shines Despite Rain

• 2011 Us TOO University Opens Diaglogue With Support Group Leaders

• Doc Moyad’s “No Bogus Science” Column – 1) Vitamin E and Prostate Cancer Death; 2) What the USPSTF Should Have Stated

• Doctor Chodak’s Bottom Line

• Read more..

• Share Hope and Donate to Us TOO

• MDV3100 Trial Stopped as Survival Improved

• Top Doctors Support PSA Screening in Men

• Brachytherapy & Risk of a Second Cancer

• Antibiotic Change Before Prostate Biopsy

• Men with a Family History of Prostate Cancer Do Not Need More Aggressive Treatment

• ADT Duration & Risk of Prostate Cancer Death

• New NCI Trial for Taxotere-Resistance Cancer

• Quanterix PSA Test to Predict PSA Recurrence

• Ask Doctor Snuffy Myers

• [11C]choline PET-CT for Detecting Pelvic Nodes

• Doc Moyad’s “No Bogus Science” Column – “Metformin and Lifestyle Changes”

• Doctor Chodak’s Bottom Line

• RT + ADT Extends Life in Advanced Cancer

• Read more..